Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cancer Res ; 52(2): 267-74, 1992 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-1728400

RESUMEN

The development of molecular dosimetry methods will simplify the identification of people at high risk for cancer. A combined monoclonal antibody immunoaffinity chromatography/high performance liquid chromatography method has been devised to isolate and quantify aflatoxin-DNA adducts and other metabolites in rat urine samples. We report the production of 11 different monoclonal antibodies recognizing aflatoxin B1, aflatoxin Q1, aflatoxin G1, aflatoxicol, and aflatoxin M1 and the application of these antibodies to a multiple monoclonal antibody affinity chromatography technique. Using the multiple monoclonal antibody affinity column with rat urines obtained from dosed animals, between 90 and 95% of total aflatoxin metabolites can be bound to the column and isolated. Analytical immunoaffinity chromatography/high performance liquid chromatography analysis of these isolated aflatoxins reveals that more than 55% of the aflatoxins in rat urine are aflatoxin-dihydrodiol, aflatoxin-N7-guanine, aflatoxin Q1, aflatoxin M1, aflatoxin P1, and aflatoxin B1, accounting for 1.5, 9.6, 1.8, 34.5, 8.0, and 1.0% of the total aflatoxins, respectively. Further, a perchloric acid digestion of the aflatoxin-N7-guanine peak was used to confirm its identity by its conversion to guanine. The measurement of aflatoxin-N7-guanine excretion in rat urine was examined to assess its utility as a marker of DNA adduct formation in the liver, and a dose-dependent excretion in urine was found with a correlation coefficient of 0.99. A comparison of the dose-dependent residual levels of aflatoxin binding to liver DNA with the amount of aflatoxin-N7-guanine excreted in urine showed a correlation coefficient of 0.98. Besides the nucleic acid adduct excretion data, aflatoxin M1 and aflatoxin P1 were evaluated as molecular dosimeters in the urine. Aflatoxin M1 was found to be an excellent marker, whereas no linear relationship between dose and aflatoxin P1 excretion in urine was found.


Asunto(s)
Aflatoxina B1/análogos & derivados , Aflatoxinas/inmunología , Guanina/análogos & derivados , Aflatoxina B1/inmunología , Aflatoxina B1/orina , Aflatoxinas/análisis , Aflatoxinas/metabolismo , Animales , Anticuerpos Monoclonales , Afinidad de Anticuerpos , Cromatografía de Afinidad , Cromatografía Líquida de Alta Presión , Guanina/inmunología , Guanina/orina , Ratas , Análisis de Regresión
2.
Pharmacogenetics ; 3(6): 275-80, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7908586

RESUMEN

The objective of this study was to determine the CYP2D6 genotype of a black Zimbabwean population. Genotyping was carried out using Eco RI and Xba I RFLP, and allele-specific PCR amplification. Of 114 Zimbabwean samples analysed, no individual homozygous for any of the defect allelic forms CYP2D6A, CYP2D6B or CYP2D6D or combinations thereof was found. The allele frequencies of the three defect genes were 0, 1.8 and 3.9%, respectively. No subject carrying the Xba I 44 kb haplotype, indicative for poor metabolizers among Caucasians, was identified, whereas five individuals being heterozygous with a 29/42 kb haplotype were seen. Three out of the four CYP2D6B alleles found were associated with the 29/42 kb haplotype. Our findings are in agreement with the 0-2% prevalence of poor metabolizers (PMs) in the black populations previously phenotyped. The very low frequency of the CYP2D6B allele in the Zimbabwean population is different from very recent data from black Americans (allele frequency = 8.5%) and might indicate the Caucasian ancestry of this allele. Taken together, our data indicate important interethnic differences in the CYP2D locus between Caucasian, Asian and different black populations.


Asunto(s)
Población Negra/genética , Sistema Enzimático del Citocromo P-450/genética , Oxigenasas de Función Mixta/genética , Polimorfismo Genético , Secuencia de Bases , Citocromo P-450 CYP2D6 , Cartilla de ADN , Genotipo , Humanos , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Zimbabwe
3.
Clin Pharmacol Ther ; 57(6): 656-61, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7781265

RESUMEN

The S-mephenytoin hydroxylase has recently been identified as cytochrome P450 2C19 (CYP2C19). This enzyme metabolizes mephenytoin, diazepam, omeprazole, and citalopram and has been shown to be polymorphically distributed. One clinical implication of CYP2C19-dependent drug metabolism for persons who reside in tropical regions is in the use of the antimalarial drug chloroguanide hydrochloride, which is apparently biotransformed to its active metabolite by this isozyme. In this investigation we studied mephenytoin metabolism in 103 black Zimbabwean Shona subjects. Four were identified as poor metabolizers (4%). This prevalence is comparable to that in white subjects (2% to 5%) but lower than the 15% to 20% incidence of poor metabolizers among Oriental subjects. Of the subjects phenotyped, 84 were genotyped for the G-->A mutation in exon 5 of CYP2C19, which creates a cryptic splice site, causing the production of a nonfunctional protein. Three of the four poor metabolizers were homozygous for this mutation, whereas the fourth one was heterozygous. The G-->A mutation has been shown to predict the incidence more than 60% of poor metabolizers among white subjects and Japanese subjects, and in the current investigation we also obtained a similar relationship in the black population.


Asunto(s)
Hidrocarburo de Aril Hidroxilasas , Sistema Enzimático del Citocromo P-450/genética , Oxigenasas de Función Mixta/genética , Adulto , Secuencia de Bases , Citocromo P-450 CYP2C19 , Etnicidad/genética , Genotipo , Humanos , Datos de Secuencia Molecular , Fenotipo , Reacción en Cadena de la Polimerasa , Zimbabwe
4.
Clin Pharmacol Ther ; 57(1): 25-31, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7828378

RESUMEN

Caffeine is increasingly used as a biochemical probe for liver function, in cancer epidemiology, and in pharmacogenetics, with its recognized ability to assess the activities of CYP1A2, xanthine oxidase, and N-acetyltransferase-2. The activity of these hepatic enzymes was tested in 45 Shona children from a rural area of Zimbabwe with use of caffeine as a probe. Many of these rural black children had lower indexes of CYP1A2 activity than otherwise on our extensive records; the average value (3.78 +/- 2.9) was significantly (p < 0.001) lower than that of healthy white urban children from Zimbabwe (8.86 +/- 3.36) or from Canada (7.92 +/- 1.88), or that of healthy Canadian adults (5.96 +/- 2.4). A higher CYP1A2 activity in children than in adults is usual. The low CYP1A2 activity of the children from rural Zimbabwe calls for medical studies and suggests a widespread and perhaps serious impairment of certain liver functions. Causes could be parasitic infections with Schistosoma mansoni, causing schistosomiasis, which are endemic, in addition to generally poor nutrition and frequent iodine deficiency. By contrast, the xanthine oxidase activity in rural Shona children was slightly higher than that reported for a healthy Canadian adult population. The N-acetyltransferase activities were comparable in both the rural and urban children and were also similar to those reported in a population study of healthy adult Canadians.


Asunto(s)
Acetiltransferasas/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Hígado/enzimología , Oxidorreductasas/metabolismo , Xantina Oxidasa/metabolismo , Adolescente , Adulto , Cafeína/metabolismo , Cafeína/orina , Canadá/etnología , Niño , Cromatografía Líquida de Alta Presión , Citocromo P-450 CYP1A2 , Femenino , Humanos , Masculino , Población Rural , Población Urbana , Zimbabwe/etnología
5.
Free Radic Biol Med ; 22(1-2): 321-7, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-8958157

RESUMEN

The effect of chloroquine (CHQ) administration on antioxidant enzymes in rat liver and kidney was studied. Male Sprague-Dawley rats were administered 20 mg/kg CHQ once a week for 4 weeks (chronic treatment) or a single dose at 10 or 20 mg/kg (acute treatment). Antioxidant enzyme activities were determined in cytosolic fractions of liver and kidney, whereas reduced glutathione (GSH) and malondialdehyde (MDA) were determined in tissue samples. Results indicate minimal effects of acute CHQ treatment, whereas chronic treatment with CHQ differentially affected antioxidant enzymes in the two organs. Superoxide dismutase activity was increased nearly twofold, while activities of selenium glutathione peroxidase (GPX), catalase, and NAD (P) H: quinone oxidoreductase were decreased in livers of CHQ-treated rats compared to controls. No significant effects of CHQ on glutathione reductase, GSH, and MDA levels were seen in the liver. Fewer effects of CHQ were observed in the kidney where a decrease in GPX activity and an increase in MDA levels was seen. Lowering of antioxidant enzymes activities in the liver by CHQ could render the organ more susceptible to subsequent oxidative stress; while increased MDA production after CHQ treatment in the kidney indicate that the organ is being subjected to oxidative stress. This could have implications for prolonged chloroquine intake.


Asunto(s)
Antimaláricos/farmacología , Antioxidantes/metabolismo , Cloroquina/farmacología , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Animales , Catalasa/metabolismo , Evaluación Preclínica de Medicamentos , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Riñón/enzimología , Hígado/enzimología , Masculino , Malondialdehído/metabolismo , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/metabolismo
6.
Biochem Pharmacol ; 48(9): 1779-83, 1994 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-7980647

RESUMEN

The metabolism of praziquantel (PZQ) was studied in microsomes isolated from livers of differently pretreated rats and in the presence of various inhibitors of cytochrome P450 (P450) isoforms. Microsomes from phenobarbitone (PB)-pretreated rats metabolised PZQ to its major metabolite 4OH-praziquantel (4OH-PZQ) at a greater rate than those from 20-methylcholanthrene (MC) and saline (SA) pretreated rats. The Vmax for the PB microsomes was 600 nmol 4OH-PZQ formed/mg/min x 10(-3) compared to 91.4 nmol/mg/min x 10(-3) for MC and 238 nmol/mg/min x 10(-3) for SA microsomes. These results indicate that PZQ is metabolised by PB-inducible isoforms of P450. Inhibitor studies were conducted with microsomes from SA-pretreated animals. In these studies, caffeine, disulfuram, and tolbutamide were poor inhibitors of the metabolism of PZQ to 4OH-PZQ, with I50 values not determinable. Quinidine and quinine inhibited the hydroxylation of PZQ but with high Ki values. 17 alpha-Ethynylestradiol, cimetidine and diphenylhydramine were effective inhibitors of the formation of 4OH-PZQ, with 17 alpha-ethynylestradiol being the most potent with a Ki of 0.5 +/- 0.05 microM. From the known specificities of these P450 inhibitors, it is therefore concluded that cytochromes P450 1A2, 2E1, 2C9-10, and 2D6 probably do not contribute significantly to the metabolism of PZQ to its major metabolite in rats. It is likely that cytochromes P450 2B1 and 3A, both inducible by PB, are predominantly responsible for the formation of 4OH-PZQ.


Asunto(s)
Inhibidores Enzimáticos del Citocromo P-450 , Microsomas Hepáticos/metabolismo , Praziquantel/metabolismo , Animales , Difenhidramina/farmacología , Hidroxilación/efectos de los fármacos , Cinética , Masculino , Quinidina/farmacología , Quinina/farmacología , Ratas , Ratas Sprague-Dawley
7.
Biochem Pharmacol ; 40(2): 379-82, 1990 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-1695846

RESUMEN

The covalent binding of [14C]acetylaminofluorene (AAF) to macromolecules in vivo and in vitro was measured in Schistosoma mansoni-infected and in non-infected mice. Liver microsomes from infected mice demonstrated a 42% decreased capacity to mediate covalent binding of AAF to DNA. In addition, the extent of binding of AAF to liver macromolecules in vivo was generally less in infected than non-infected mice.


Asunto(s)
2-Acetilaminofluoreno/metabolismo , Hígado/metabolismo , Esquistosomiasis/metabolismo , Animales , ADN/metabolismo , Técnicas In Vitro , Ratones , Ratones Endogámicos BALB C , Unión Proteica , ARN/metabolismo
8.
Int J Epidemiol ; 16(4): 516-9, 1987 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3440662

RESUMEN

In this study, 1228 urine samples were collected from different centres in Zimbabwe and were analysed for aflatoxin contamination. The urine samples were extracted with chloroform and analysed by thin layer chromatography and high-performance liquid chromatography. The most commonly observed contaminant was aflatoxin M1, at an average concentration of 4.2 ng/ml of urine. Although the national average of urine samples contaminated was 4.3%, there were areas in which up to 10% of the urine samples were contaminated.


Asunto(s)
Aflatoxinas/orina , Femenino , Geografía , Humanos , Masculino , Distribución Aleatoria , Zimbabwe
9.
Free Radic Res ; 27(2): 173-9, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9350421

RESUMEN

The effects of primaquine treatment on antioxidant enzyme activities were investigated in rat liver and kidney. Male Sprague-Dawley rats were treated with 0.21 mg/kg daily for two weeks (chronic treatment) or a single dose at 0.21 or 0.63 mg/kg. Antioxidant enzyme activities were determined in liver and kidney cytosolic fractions whereas glutathione (GSH) and malondialdehyde (MDA) levels were determined in tissue samples. Results for the liver showed increases in cytosolic superoxide dismutase (SOD) and glutathione peroxidase (GPX) enzymatic activities after chronic primaquine treatment. Levels of MDA, a marker for lipid peroxidation, were also increased by more than 50% indicating enhanced oxidative damage in the liver. In the single dose study, 0.63 mg/kg primaquine caused a more than 100% increase in liver SOD and a 36% increase in NAD (P) H: quinone oxidoreductase (NQOR) activities. Results for the kidney, however, showed fewer primaquine-induced changes in antioxidant enzyme activities when compared to the liver in both the chronic and single dose studies. Overall, our results indicate that primaquine treatment causes an oxidative stress in the two rat organs. These results are consistent with the known pro-oxidant effects of primaquine in vivo, and supplement current knowledge on the effects of antimalarial drugs on various enzyme systems.


Asunto(s)
Catalasa/metabolismo , Glutatión Peroxidasa/metabolismo , Riñón/enzimología , Hígado/enzimología , Primaquina/farmacología , Superóxido Dismutasa/metabolismo , Animales , Antimaláricos/farmacología , Citosol/enzimología , Esquema de Medicación , Glutatión/metabolismo , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley
10.
Free Radic Res ; 35(4): 427-34, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11697139

RESUMEN

Artemisinin is a sesquiterpene lactone containing an endoperoxide bridge. It is a promising new antimalarial and is particularly useful against the drug resistant strains of Plasmodium falciparum. It has unique antimalarial properties since it acts through the generation of free radicals that alkylate parasite proteins. Since the antimalarial action of the drug is antagonised by glutathione and ascorbate and has unusual pharmacokinetic properties in humans, we have investigated if the drug is broken down by a typical reductive reaction in the presence of glutathione transferases. Cytosolic glutathione transferases (GSTs) detoxify electrophilic xenobiotics by catalysing the formation of glutathione (GSH) conjugates and exhibit glutathione peroxidase activity towards hydroperoxides. Artemisinin was incubated with glutathione, NADPH and glutathione reductase and GSTs in a coupled assay system analogous to the standard assay scheme with cumene hydroperoxide as a substrate of GSTs. Artemisinin was shown to stimulate NADPH oxidation in cytosols from rat liver, kidney, intestines and in affinity purified preparations of GSTs from rat liver. Using human recombinant GSTs hetelorogously expressed in Escherichia coli, artemisinin was similarly shown to stimulate NADPH oxidation with the highest activity observed with GST M1-1. Using recombinant GSTs the activity of GSTs with artemisinin was at least two fold higher than the reaction with CDNB. Considering these results, it is possible that GSTs may contribute to the metabolism of artemisinin in the presence of NADPH and GSSG-reductase. We propose a model, based on the known reactions of GSTs and sesquiterpenes, in which (1) artemisinin reacts with GSH resulting in oxidised glutathione; (2) the oxidised glutathione is then converted to reduced glutathione via glutathione reductase; and (3) the latter reaction may then result in the depletion of NADPH via GSSG-reductase. The ability of artemisinin to react with GSH in the presence of GST may be responsible for the NADPH utilisation observed in vitro and suggests that cytosolic GSTs are likely to be contributing to metabolism of artemisinin and related drugs in vivo.


Asunto(s)
Antimaláricos/metabolismo , Artemisininas , Glutatión Transferasa/metabolismo , Sesquiterpenos/metabolismo , Animales , Derivados del Benceno/metabolismo , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Gutatión-S-Transferasa pi , Humanos , Técnicas In Vitro , Isoenzimas/metabolismo , Riñón/enzimología , Hígado/enzimología , Masculino , NADP/metabolismo , Oxidación-Reducción , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/metabolismo
11.
Brain Res Bull ; 44(5): 561-71, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9365799

RESUMEN

Metabolism of most drugs influences their pharmacological and toxicological effects. Drugs particularly affected are those with a narrow therapeutic window and that are subjected to considerable first-pass metabolism. Much of the interindividual and interethnic differences in effects of drugs is now attributable to genetic differences in their metabolism. Genetic polymorphisms have been described for many drug-metabolising enzymes in Caucasian and Oriental populations, the most well-characterised being those for cytochrome P450 2D6, cytochrome P450 2C19, glutathione S-transferases, and N-acetyl transferase 2. African populations have been studied to a lesser extent, but it is apparent that populations within Africa are heterogeneous with respect to these polymorphisms. In addition, although some allelic variants are common to all populations throughout the world (e.g., CYP2D6*5), some allelic variants are specific for an African population (e.g., CYP2D6*17). The polymorphisms give rise to enzymes with changed or no activity towards drug substrates. Two of the most important enzymes for metabolism of neuroleptics and other psychoactive drugs are CYP2D6 and CYP2C19. This article compares the current information on polymorphisms of these two enzymes in African and other populations and discusses the implications of these polymorphisms for neuropharmacotherapy.


Asunto(s)
Antidepresivos/farmacocinética , Antipsicóticos/farmacocinética , Hidrocarburo de Aril Hidroxilasas , Población Negra/genética , Citocromo P-450 CYP2D6/genética , Sistema Enzimático del Citocromo P-450/genética , Oxigenasas de Función Mixta/genética , Polimorfismo Genético , África , Alelos , Citocromo P-450 CYP2C19 , Citocromo P-450 CYP2D6/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Variación Genética , Humanos , Oxigenasas de Función Mixta/metabolismo , Especificidad por Sustrato
12.
Clin Chim Acta ; 265(2): 145-55, 1997 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-9385457

RESUMEN

The frequency of the null allele phenotype of glutathione S-transferase (GST) M1 was investigated in 114 Zimbabweans and results for a subset of 63 subjects were compared with genotyping by PCR. In addition, the effect of the antimalarial chloroquine on blood levels of GSTM1 and GSTA in 19 subjects was studied. Quantification of GSTs was by enzyme linked immunosorbent assays (ELISA). Thirty percent of the subjects were of the GSTM1 null phenotype. Comparison of results of phenotyping by ELISA and genotyping by PCR showed that 16% of samples were in discordance; unknown mutations in the GSTM1 gene in the Zimbabwean population may explain this observation. Chloroquine decreased levels of blood GSTM1 and GSTA by 50% or more. In populations treated with chloroquine, these decreases in GST activities might lead to compromised ability to detoxify xenobiotics, could confound GSTM1 phenotyping and might invalidate use of GSTA as an indicator of liver damage.


Asunto(s)
Antimaláricos/farmacología , Cloroquina/farmacología , Glutatión Transferasa/sangre , Glutatión Transferasa/efectos de los fármacos , Isoenzimas/sangre , Isoenzimas/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Glutatión Transferasa/genética , Humanos , Isoenzimas/genética , Masculino , Fenotipo , Polimorfismo Genético
13.
J Insect Physiol ; 49(3): 223-9, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12769997

RESUMEN

The presence of glutathione transferases and esterase activity was investigated in Rhopalosiphum padi and the effects of the cereal hydroxamic acid, 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) on these detoxification enzymes was studied. Activity of glutathione S-transferases and general esterases was determined for adult aphids feeding on a natural diet lacking DIMBOA and on an artificial DIMBOA-containing diet for 48 hours. In vivo, DIMBOA in the diet inhibited the activities of esterases by 50-75% at all concentrations tested (0.5-4 mM). The activity of glutathione transferase was inhibited to a lesser extent (30%) at the higher concentrations of DIMBOA. In vitro, DIMBOA generally inhibited the activity of esterases with an IC(50) of 33 micro M, and had a slight inhibitory effect on glutathione S-transferases. These effects of DIMBOA could make the aphids vulnerable to electrophilic agents and insecticides which may be metabolized via esterases and GSTs. In cereals, therefore, DIMBOA may act by interfering with esterase- or GST-mediated detoxification of xenobiotics by aphids.


Asunto(s)
Áfidos/enzimología , Esterasas/metabolismo , Glutatión Transferasa/metabolismo , Insecticidas/farmacocinética , Oxazinas/farmacología , Animales , Benzoxazinas , Dieta , Relación Dosis-Respuesta a Droga , Grano Comestible , Esterasas/efectos de los fármacos , Glutatión Transferasa/antagonistas & inhibidores , Glutatión Transferasa/efectos de los fármacos , Inactivación Metabólica , Cinética
14.
Cent Afr J Med ; 35(12): 542-5, 1989 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2485709

RESUMEN

In this communication, we report the detection of aflatoxins in human urine and breast milk. The 2553 urine samples were collected from donors of different ages and sexes at centres throughout Zimbabwe, while 54 breast milk samples were collected from breast feeding mothers. The most predominant aflatoxins found were AFM and AFG. The national average of urine samples contaminated was 6.0 percent. There were, however, some areas in which the extent of contamination was 34 percent. Of the 54 breast milk samples collected, 11 percent were contaminated mainly with AFM.


Asunto(s)
Aflatoxinas/análisis , Exposición a Riesgos Ambientales , Leche Humana/química , Aflatoxinas/orina , Altitud , Monitoreo del Ambiente , Humanos , Zimbabwe
15.
Eur J Drug Metab Pharmacokinet ; 18(3): 261-4, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8149944

RESUMEN

The effects of phenobarbital (PB) and 3-methylcholanthrene (MC) pretreatment on the pharmacokinetics of praziquantel (PZQ), a schistosomicide were studied in Sprague-Dawley rats. Blood samples at different time intervals were obtained by severing the tail vein and were analyzed for unchanged PZQ by HPLC. The PB-pretreated rats showed a 6-fold decrease in AUC, a 5-fold decrease in Cmax and an 8-fold increase in CLtot compared to the saline treated controls. The MC-pretreated rats and their olive-oil treated controls did not show any statistically significant differences in the above parameters. These results suggest that PZQ is extensively metabolised by PB-inducible cytochrome P-450 isoforms and not by MC-inducible isoforms. These findings also suggest that the bioavailability of praziquantel could be altered to a significant extent in humans taking drugs that are phenobarbital type inducers.


Asunto(s)
Metilcolantreno/farmacología , Fenobarbital/farmacología , Praziquantel/farmacocinética , Animales , Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Interacciones Farmacológicas , Inducción Enzimática , Masculino , Metilcolantreno/administración & dosificación , Fenobarbital/administración & dosificación , Premedicación , Ratas , Ratas Sprague-Dawley
18.
J Egypt Soc Parasitol ; 25(1): 157-63, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7602158

RESUMEN

Zoxazolamine paralysis times have been used as a probe to measure the activities of cytochrome P450 1A1 in mice in vivo. The results indicate that male and female mice of the BALB/c and CBA/J strain do not show altered paralysis times if infected with less than 4 worm pairs. Alterations were observed only in animals harbouring more than 5 worm pairs irrespective of the sex or strain of mouse being used. The study has extended the findings of other workers showing that mice infected with fewer than 4-5 worm pairs of S. mansoni do not show any alteration in the metabolism of pentobarbital in vivo.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Hígado/metabolismo , Schistosoma mansoni/fisiología , Esquistosomiasis mansoni/metabolismo , Zoxazolamina/farmacocinética , Animales , Femenino , Inactivación Metabólica , Hígado/parasitología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos CBA , Parálisis/inducido químicamente , Esquistosomiasis mansoni/parasitología , Zoxazolamina/farmacología
19.
Artículo en Inglés | MEDLINE | ID: mdl-1980442

RESUMEN

1. In a previous study of the marine sponge Geodia mesotriaena von Lendenfeld for antineoplastic constituents, evidence was obtained for the presence of several toxins and geodiatoxin 1 was isolated. 2. Further separations guided by bioassay using CDF1 mice have led to the isolation of three additional chromoprotein toxins lethal at 8 mg/kg.


Asunto(s)
Toxinas Marinas/aislamiento & purificación , Poríferos/análisis , Animales , Antineoplásicos/aislamiento & purificación , Dosificación Letal Mediana , Leucemia P388/tratamiento farmacológico , Toxinas Marinas/farmacología , Ratones , Células Tumorales Cultivadas
20.
Biopharm Drug Dispos ; 15(1): 33-43, 1994 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8161714

RESUMEN

It is likely that a proportion of people treated with the anti-schistosomicidal drug praziquantel (PZQ) is also taking other drugs such as chloroquine (CHQ), a widely used anti-malarial. The effect of CHQ on the pharmacokinetics and metabolism of PZQ in rats and in humans was therefore studied. CHQ decreased the bioavailability of PZQ and reduced its maximum serum concentrations to a significant extent in rats and in humans. The clearance was increased to a statistically significant extent in rats but not in humans because of the wide interindividual variation. The effect of CHQ on PZQ pharmacokinetics was unexpected since drugs that inhibit hepatic drug metabolism usually increase the bioavailability of PZQ. We found that CHQ inhibits non-competitively the metabolism of PZQ to its major metabolite, 4-hydroxy-praziquantel, with a Ki of 1.65 mM in rat hepatic microsomes. Maximum concentrations attained by CHQ in serum, however, are low compared to the Ki value and significant inhibition is therefore unlikely in vivo. The explanation for CHQ's effect on the pharmacokinetics of PZQ may be due to other effects of CHQ rather than to a direct effect on drug-metabolizing enzymes.


Asunto(s)
Cloroquina/farmacología , Microsomas Hepáticos/efectos de los fármacos , Praziquantel/farmacocinética , Adulto , Animales , Disponibilidad Biológica , Dexametasona/farmacología , Interacciones Farmacológicas , Humanos , Masculino , Microsomas Hepáticos/metabolismo , Praziquantel/sangre , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA